PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 16 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $33,394,000 | +1.3% | 31,733,000 | +10.4% | 0.02% | -6.2% |
| Q1 2019 | $32,954,000 | +28.9% | 28,733,000 | +14.0% | 0.02% | +14.3% |
| Q4 2018 | $25,569,000 | +17.1% | 25,195,000 | +13.5% | 0.01% | +40.0% |
| Q3 2018 | $21,837,000 | +7.2% | 22,195,000 | +0.2% | 0.01% | 0.0% |
| Q2 2018 | $20,375,000 | -10.0% | 22,150,000 | 0.0% | 0.01% | -16.7% |
| Q1 2018 | $22,638,000 | +4.3% | 22,150,000 | 0.0% | 0.01% | -7.7% |
| Q4 2017 | $21,713,000 | -10.0% | 22,150,000 | 0.0% | 0.01% | -31.6% |
| Q3 2017 | $24,117,000 | +130.4% | 22,150,000 | +90.9% | 0.02% | +111.1% |
| Q2 2017 | $10,467,000 | +48.7% | 11,600,000 | +45.0% | 0.01% | +50.0% |
| Q1 2017 | $7,038,000 | -25.0% | 8,000,000 | -30.4% | 0.01% | -33.3% |
| Q4 2016 | $9,379,000 | – | 11,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 8,575,000 | $7,002,000 | 7.67% |
| Man Investments (CH) AG | 4,500,000 | $3,645,000 | 2.12% |
| Park West Asset Management LLC | 22,250,000 | $17,870,000 | 1.38% |
| Telemetry Investments, L.L.C. | 3,000,000 | $2,409,000 | 1.36% |
| WHITEBOX ADVISORS LLC | 27,961,000 | $22,456,000 | 0.89% |
| Kissinger Financial Services LLC | 2,652,000 | $2,127,000 | 0.74% |
| ZAZOVE ASSOCIATES LLC | 9,560,000 | $7,839,000 | 0.37% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,700,000 | $13,528,000 | 0.18% |
| LINDEN ADVISORS LP | 4,000,000 | $3,253,000 | 0.13% |
| AQR Arbitrage LLC | 5,000,000 | $4,041,000 | 0.04% |